Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000604574> ?p ?o ?g. }
- W2000604574 endingPage "401" @default.
- W2000604574 startingPage "394" @default.
- W2000604574 abstract "Doxorubicin is an effective anticancer chemotherapeutic agent known to cause acute and chronic cardiomyopathy. To develop a more sensitive echocardiographic screening test for cardiac damage due to doxorubicin, a cohort study was performed using dobutamine infusion to differentiate asymptomatic long-term survivors of childhood cancer treated with doxorubicin from healthy control subjects. Echocardiographic data from the experimental group of 21 patients (mean age 16 ± 5 years) treated from 1.6 to 14.3 years (median 5.3) before this study with 27 to 532 mg/m2of doxorubicin (mean 196) were compared with echocardiographic data from 12 normal age-matched control subjects. Graded dobutamine infusions of 0.5, 2.5, 5 and 10 μg/kg per min were administered. Echocardiographic Doppler studies were per formed before infusion and after 15 min of infusion at each rate. Dobutamine infusion at 10 μg/kg per min was discontinued after six studies secondary to a 50% incidence rate of adverse symptoms. The most important findings were that compared with values in control subjects, end-systolic left ventricular posterior wall dimension and percent of left ventricular posterior wall thickening in doxorubicin-treated patients were decreased at baseline study and these findings wert more clearly delineated with dobutamine stimulation. End-systolic left ventricular posterior wall dimension at baseline for the doxorubicin-treated group was 11 ± 1.9 mm versus 13.1 ± 1.5 mm for control subjects (p < 0.01). End-systolic left ventricular posterior wall dimension at the 5- μg/kg per min dobutamine infusion for the doxorubicin-treated group was 14.1 ± 2.4 mm versus 19.3 ± 2.6 mm for control subjects (p < 0.01). Percent left ventricular posterior wall thickening at baseline for the doxorubicin-treated group was 78 ± 18% versus 97 ± 13% for the control group (p < 0.01). Percent left ventricular posterior wall thickening at the 5- μg/kg per min dobutamine infusion for the doxorubicin-treated group was 121 ± 37% versus 185 ± 20% for the control group (p < 0.01). Decreased left ventricular shortening fraction and increased left ventricular end-systolic meridional wall stress were demonstrated in doxorubicin-treated patients only during dobutamine infusion. No differences were found between results in control subjects and doxorubicin-treated patients for measured diastolic variables. Thus, asymptomatic long-term survivors of childhood cancer treated with doxorubicin may have latent decreased cardiac performance that is undetected by commonly used echocardiographic methods, including rest left ventricular shortening fraction and left ventricular end-systolic meriodional wall stress. Our data establish that evaluation of left ventricular systolic function by end-systolic posterior wall dimension, posterior wall thickening, end-systolic meridional wall stress and shortening fraction measured during inotropic stimulation with dobutamine provides a sensitive technique for examining the cardiac status of asymptomatic doxorubicin-treated patients." @default.
- W2000604574 created "2016-06-24" @default.
- W2000604574 creator A5013334801 @default.
- W2000604574 creator A5058693463 @default.
- W2000604574 creator A5063727362 @default.
- W2000604574 creator A5068038214 @default.
- W2000604574 creator A5089609243 @default.
- W2000604574 date "1992-02-01" @default.
- W2000604574 modified "2023-10-10" @default.
- W2000604574 title "Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer" @default.
- W2000604574 cites W17905924 @default.
- W2000604574 cites W1892378723 @default.
- W2000604574 cites W1965150830 @default.
- W2000604574 cites W1966377054 @default.
- W2000604574 cites W1970007537 @default.
- W2000604574 cites W1973494912 @default.
- W2000604574 cites W1976559365 @default.
- W2000604574 cites W1988864975 @default.
- W2000604574 cites W1997900909 @default.
- W2000604574 cites W2006010513 @default.
- W2000604574 cites W2007580937 @default.
- W2000604574 cites W2028137315 @default.
- W2000604574 cites W2039009936 @default.
- W2000604574 cites W2049129583 @default.
- W2000604574 cites W2058337944 @default.
- W2000604574 cites W2058563509 @default.
- W2000604574 cites W2065475985 @default.
- W2000604574 cites W2065634263 @default.
- W2000604574 cites W2067982278 @default.
- W2000604574 cites W2071657527 @default.
- W2000604574 cites W2072371345 @default.
- W2000604574 cites W2086885737 @default.
- W2000604574 cites W2087585549 @default.
- W2000604574 cites W2096073058 @default.
- W2000604574 cites W2104475665 @default.
- W2000604574 cites W2111426313 @default.
- W2000604574 cites W2133528851 @default.
- W2000604574 cites W2156982022 @default.
- W2000604574 cites W4246237837 @default.
- W2000604574 cites W4298102334 @default.
- W2000604574 doi "https://doi.org/10.1016/0735-1097(92)90497-b" @default.
- W2000604574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1732369" @default.
- W2000604574 hasPublicationYear "1992" @default.
- W2000604574 type Work @default.
- W2000604574 sameAs 2000604574 @default.
- W2000604574 citedByCount "126" @default.
- W2000604574 countsByYear W20006045742012 @default.
- W2000604574 countsByYear W20006045742013 @default.
- W2000604574 countsByYear W20006045742015 @default.
- W2000604574 countsByYear W20006045742016 @default.
- W2000604574 countsByYear W20006045742017 @default.
- W2000604574 countsByYear W20006045742018 @default.
- W2000604574 countsByYear W20006045742019 @default.
- W2000604574 countsByYear W20006045742020 @default.
- W2000604574 countsByYear W20006045742021 @default.
- W2000604574 countsByYear W20006045742022 @default.
- W2000604574 countsByYear W20006045742023 @default.
- W2000604574 crossrefType "journal-article" @default.
- W2000604574 hasAuthorship W2000604574A5013334801 @default.
- W2000604574 hasAuthorship W2000604574A5058693463 @default.
- W2000604574 hasAuthorship W2000604574A5063727362 @default.
- W2000604574 hasAuthorship W2000604574A5068038214 @default.
- W2000604574 hasAuthorship W2000604574A5089609243 @default.
- W2000604574 hasBestOaLocation W20006045741 @default.
- W2000604574 hasConcept C126322002 @default.
- W2000604574 hasConcept C164705383 @default.
- W2000604574 hasConcept C178853913 @default.
- W2000604574 hasConcept C2776694085 @default.
- W2000604574 hasConcept C2777910003 @default.
- W2000604574 hasConcept C2778198053 @default.
- W2000604574 hasConcept C2778797674 @default.
- W2000604574 hasConcept C2781185063 @default.
- W2000604574 hasConcept C2781303535 @default.
- W2000604574 hasConcept C42219234 @default.
- W2000604574 hasConcept C71924100 @default.
- W2000604574 hasConceptScore W2000604574C126322002 @default.
- W2000604574 hasConceptScore W2000604574C164705383 @default.
- W2000604574 hasConceptScore W2000604574C178853913 @default.
- W2000604574 hasConceptScore W2000604574C2776694085 @default.
- W2000604574 hasConceptScore W2000604574C2777910003 @default.
- W2000604574 hasConceptScore W2000604574C2778198053 @default.
- W2000604574 hasConceptScore W2000604574C2778797674 @default.
- W2000604574 hasConceptScore W2000604574C2781185063 @default.
- W2000604574 hasConceptScore W2000604574C2781303535 @default.
- W2000604574 hasConceptScore W2000604574C42219234 @default.
- W2000604574 hasConceptScore W2000604574C71924100 @default.
- W2000604574 hasIssue "2" @default.
- W2000604574 hasLocation W20006045741 @default.
- W2000604574 hasLocation W20006045742 @default.
- W2000604574 hasOpenAccess W2000604574 @default.
- W2000604574 hasPrimaryLocation W20006045741 @default.
- W2000604574 hasRelatedWork W2030875469 @default.
- W2000604574 hasRelatedWork W2049776456 @default.
- W2000604574 hasRelatedWork W2057736164 @default.
- W2000604574 hasRelatedWork W2075251017 @default.
- W2000604574 hasRelatedWork W2076813506 @default.
- W2000604574 hasRelatedWork W2097753790 @default.
- W2000604574 hasRelatedWork W2388274277 @default.